InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Saturday, 06/20/2020 9:49:12 PM

Saturday, June 20, 2020 9:49:12 PM

Post# of 16699
AGN is currently a speculative OTC Biopharma now. The transition /dilution from BTH>NASH/AGN was better than the possible $.00 a BK would have left.
I thought it might go down like some other OTC bets, win some lose some. Good ideas dont mean good stocks and visa/versa. I try to just figure out what is best for me. BTH made a good climb in '18. AGN has huge possibilities, IMO.
There are the possibilities now of some successes and Real world Clinical Trials should occur soon. Data will rule the future. Masks Optional.